1. “Alleviated hyperandrogenism in PCOS rats as evidenced by reduced serum levels of T and increased E2 and FSH levels” 2. “Reduced the phosphorylation of NF-κB p65 and increased the expression of IκB” 3. “SGD could ameliorate hyperandrogenism in PCOS rats, and the potential mechanism may relate to the NF-κB pathway”. Here, NFKB1 is linked to polycystic ovary syndrome.